SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0
http://www.w3.org/2000/01/rdf-schema#comment
"Study have provided evidence that ASPP2 has an inhibitory influence on triplenegative breast cancer (TNBC) growth and metastasis and that this may rely on using the PI3K/AKT pathway in a p53independent manner."
xsd:string
http://purl.uniprot.org/uniprot/#_3D86C081610F0B045F657768587AC1398FA4E7B5F89ED44EEF8B263FA0267B494627FDE54A63991591508D08D0F65AE2
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0
http://purl.uniprot.org/uniprot/B4DH76
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0
http://purl.uniprot.org/uniprot/#_B4DH76-mappedCitation-29568874
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/572488665C1B091BE6C7B26297A2EA2CE16A285551A6DB86CE857B22F3D9893A54BF2F48C5A66108A1EFDA316ABF95E0